HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Rubin, C. E. Search for Related Content PubMed Articles by Rubin, C. E.

CA: A Cancer Journal for Clinicians, Vol 6, 136-140, Copyright © 1956 by American Cancer Society

CANCER CLINICS

¹ Gastroenterology Section, Department of Medicine, University of Washington, Settle, Washington

Dr. Rubin: Thank you. In conclusion I would like to emphasize the positive aspects of this depressing problem of gastric malignant tumors. We have presented a rare but relatively hopeful type of gastric cancer. Admittedly our cure rate for the usual type of adenocarcinoma is very low despite continued improvement of surgical therapy. By early accurate diagnoses the physician may avail himself more completely of the benefits of currently available surgical techniques. Selective screening of certain asymptomatic cancer-prone patients is desirable, for it will detect some curable disease. These approaches will undoubtedly increase our cure rate, but unfortunately many will continue to die despite our efforts. In order to maintain a proper perspective, one must try to remember that statistics do not matter to the cured patients; for them, it is 100 per cent. One must use the best methods available until more definitive preventive, palliative, and curative measures are developed. They are being eagerly sought and probably will be found when we have more knowledge regarding the pathogenesis of human gastric cancer.